Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Fighting against antimicrobial resistance
Antimicrobial resistance is a global problem that requires commitment to tackle it, shares EU Health Commissioner Vytenis Andriukaitis in a speech.
New Foot-and-Mouth Disease virus vaccines
University of St Andrews’ Martin Ryan PhD talks about zoonotic diseases such as Foot-and-Mouth Disease and importance of vaccinations
Parasitic infection: Animal health matters too
Professor Colin J Suckling explains how teams at the University of Strathclyde and University of Glasgow are challenging global parasitic infection
Cows, horse, camels
When people...
Tackling cognitive decline in Alzheimer’s disease
Ai-Ling Lin PhD, of The Lin Brain Lab talks about the reversal of cognitive decline in Alzheimer’s disease with comprehensive and personalised nutrition
Alzheimer’s disease...
Ambitious plan to reduce smoking rates in England published
The government has announced their plans to cut smoking rates in England among adults from 15.5% to no more than 12% by 2022
NRD.E1 – a treatment for diabetic related neuropathic pain
Novaremed’s Dr Eli Kaplan shares research on NRD.E1 and explains how it can help to treat diabetic related neuropathic pain
Poverty and its impact on the health of children
One of the main risks to children’s health is living in poverty, says Royal College of Paediatrics and Child Health’s Professor Russell Viner
Childhood cancer trends: how to interpret new findings
Dr Eva Steliarova, Scientist at IARC’s Section of Cancer Surveillance explains how research results can be used to reduce the burden of cancer in children
Huntington’s disease: Understanding the impact
Jennifer Simpson of the Huntington’s disease Society of America highlights the disease and how there is still a long way to go before it can be truly understood
Understanding acute respiratory distress syndrome
TAURA is a research project that aims to fill in knowledge gaps in acute respiratory distress syndrome. Associate Professor Matthieu Jabaudon explains
EU member states vote on hormone-disrupting chemicals criteria
A list of criteria relating to hormone-disrupting chemicals has been approved by member states, edging closer towards regulation
What’s new in Parkinson’s rating scales?
Parkinson’s rating scales are a vital assessment tool, but have their limitations. Jennifer Stratten explains how and why the EPDA developed a new one
HIV transmission stigma still persists despite scientific evidence
A new campaign from the Terrence Higgins Trust aims to debunk some of the myths and beliefs surrounding HIV
NHS bosses backtrack on controversial budget cuts
Backlash for plans to save money by delaying operations, treatment and closing wards sees NHS bosses do a u-turn
Cancer immunotherapy: Are we ready to take the next big step?
Sumith A Kularatne of On Target Laboratories, LLC highlights cancer immunotherapy as the treatment of the year to target cancer cells
Identifying pancreatic cysts that might turn into cancer
There are many challenges associated with identifying potentially cancerous pancreatic cysts. Here, Dr. Annabelle L. Fonseca et al explain
Type 1 diabetes: A serious chronic disease
University of Oulu’s Professor Riitta Veijola discusses the impact of Type 1 diabetes on society and the challenges associated with tackling the disease
CATCH-IT: helping to prevent depression and mental illness
University of Illinois’ Dr. Benjamin Van Voorhees explains how the CATCH-IT intervention is fighting against depression using a behavioural vaccine approach
Hospitals to get extra funding to cope with winter pressures
Secretary of State for Health, Jeremy Hunt has announced £20m of extra funding for hospitals to ease pressure on emergency departments ahead of next winter
Pharmacogenomics of polypharmacy in Alzheimer’s disease
Ramón Cacabelos of EuroEspes Biomedical Research Center details how the incorporation of pharmacogenomics to treat Alzheimer’s patients is crucial
